Discontinuation report AXERT 6.25MG
| Report ID | 27333 |
| Drug Identification Number | 02248128 |
| Brand name | AXERT 6.25MG |
| Common or Proper name | AXERT |
| Company Name | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | ALMOTRIPTAN |
| Strength(s) | 6.25MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 6 TABLETS |
| ATC code | N02CC |
| ATC description | ANTIMIGRAINE PREPARATIONS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2017-10-27 |
| Actual discontinuation date | 2017-10-27 |
| Remaining supply date | 2017-10-27 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | All stock has been depleted. |
| Company comments | J&J North American decision to exit the business. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 88 MCNABB STREET MARKHAM, ONTARIO CANADA L3R 5L2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2017-10-28 | English | Compare |
| v4 | 2017-10-27 | French | Compare |
| v3 | 2017-10-27 | English | Compare |
| v2 | 2017-10-27 | English | Compare |
| v1 | 2017-10-27 | English | Compare |
Showing 1 to 5 of 5